Imago Biosciences Probability of Future Stock Price Finishing Over 0.0
Imago Biosciences' future price is the expected price of Imago Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Imago Biosciences performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Please specify Imago Biosciences' target price for which you would like Imago Biosciences odds to be computed.
Imago |
Imago Biosciences Target Price Odds to finish over 0.0
The tendency of Imago Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.00 | 90 days | 0.00 | about 97.0 |
Based on a normal probability distribution, the odds of Imago Biosciences to move above the current price in 90 days from now is about 97.0 (This Imago Biosciences probability density function shows the probability of Imago Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.74 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Imago Biosciences will likely underperform. Moreover Imago Biosciences has an alpha of 1.4579, implying that it can generate a 1.46 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Imago Biosciences Price Density |
| Price |
Predictive Modules for Imago Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Imago Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Imago Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Imago Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Imago Biosciences is not an exception. The market had few large corrections towards the Imago Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Imago Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Imago Biosciences within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 1.46 | |
β | Beta against NYSE Composite | 3.74 | |
σ | Overall volatility | 13.19 | |
Ir | Information ratio | 0.13 |
Imago Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Imago Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Imago Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Imago Biosciences is not yet fully synchronised with the market data | |
| Imago Biosciences has some characteristics of a very speculative penny stock | |
| Imago Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (42.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Imago Biosciences currently holds about 190.01 M in cash with (39.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.63. | |
| Over 96.0% of the company shares are owned by institutional investors |
Imago Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Imago Stock often depends not only on the future outlook of the current and potential Imago Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Imago Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.4 M | |
| Cash And Short Term Investments | 217.4 M |
Imago Biosciences Technical Analysis
Imago Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Imago Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Imago Biosciences. In general, you should focus on analyzing Imago Stock price patterns and their correlations with different microeconomic environments and drivers.
Imago Biosciences Predictive Forecast Models
Imago Biosciences' time-series forecasting models is one of many Imago Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Imago Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Imago Biosciences
Checking the ongoing alerts about Imago Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Imago Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Imago Biosciences is not yet fully synchronised with the market data | |
| Imago Biosciences has some characteristics of a very speculative penny stock | |
| Imago Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (42.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Imago Biosciences currently holds about 190.01 M in cash with (39.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.63. | |
| Over 96.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Imago Biosciences information on this page should be used as a complementary analysis to other Imago Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Imago Stock
If you are still planning to invest in Imago Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Imago Biosciences' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |